Nick’s Note: Regular readers know Jeff Brown as a Silicon Valley insider with nearly 30 years of experience in the high-tech field. So when he uncovers a new technology investing trend, we share his insights with Daily readers.
Today, Jeff shows how one medical trend will rewrite healthcare as we know it, and allow you to live well past 100 years…
By Jeff Brown, editor, The Near Future Report
Our inability to precisely measure the present state of the human condition is a major weakness of the medical system.
Even today, physicians react to symptoms they see, rather than proactively identifying early indications of disease or unhealthy imbalances in a patient’s physiology.
The scale of this problem is hard to overestimate. According to a British study, 10,000 people die of cancer each year in Britain because they’re diagnosed too late.
And that’s just cancer. The trends are similar for conditions like HIV, Parkinson’s, and strokes.
But thanks to one rapidly developing medical trend, that’s changing.
I’m referring to personalized, or predictive, medicine.
Essentially, researchers have found a way to use “immunoassays” to diagnose patients. (An immunoassay is a test used to measure the concentration of a molecule in a solution—for example, a drop of blood or saliva.)
In recent years, scientists and doctors have begun using complex machines to run immunoassays and identify “biomarkers.” These biomarkers provide early indications of diseases like cancer and HIV, or conditions like concussions or inflammation.
| Recommended Link | |||
|
|||
| — |
The process of using these machines for diagnoses is like testing a patient’s blood for cholesterol levels.
In other words, this technology takes something as complex as identifying early signs of life-threatening diseases… and makes it as simple as a common blood test.
Here’s where it gets interesting…
The technology being used is, on average, 1,000 times more sensitive than the diagnostic tools being used today.
That means doctors will be able to diagnose diseases in their earliest stages, sometimes years before the symptoms are present.
The technology I’ll show you shortly could add decades to your life, and let you enjoy those extra years with the health and strength you had in your thirties and forties…
And here’s the best part: This technology won’t be reserved for the ultra-wealthy…
| Recommended Link | |||
|
Larry King to Reveal Retirement Crisis Solution??
|
|||
| — |
An Industry Disruption
The Centers for Disease Control and Prevention estimates that 75% of the nation’s healthcare spending goes to treating chronic diseases like cancer, diabetes, and heart disease.
All of these diseases can be treated much more effectively and at a much lower cost when detected early.
The cost savings of personalized medicine will mean that insurance companies will begin to cover these immunoassay screenings. After all, the insurance companies know that detecting diseases early means they’ll spend less on healthcare down the road.
We’re already seeing this happen in a similar diagnostic technology—genetic sequencing.
As I’ve said in the past, the cost to sequence—or blueprint—your genome (your entire genetic makeup) is falling rapidly. The cost has dropped to only about $1,000 from $10 million as recently as 2008. Soon, it will cost just $100.
Overall, this progression is far faster than that of Moore’s Law, which accurately predicted that the processing power of microprocessors (semiconductors) would roughly double every two years.
Now, unless you’ve been working in the technology sector for a few decades, it might be hard to grasp the significance of this. But I’ve worked as a high-technology executive for 25 years. So take my word for it… To date, nothing in the world of technology has developed this quickly.
As of November 1, 2017, UnitedHealthcare began covering “whole exome sequencing for patients where clinical presentation is non-specific and does not fit a well-defined syndrome.”
In other words, if a physician knows something is wrong with a patient, but can’t figure out what it is, UnitedHealthcare will pay to have the patient’s whole exome sequenced. (The exome is a subset of the genome that contains many of the most important DNA sequences.)
The same thing will happen with these ultra-sensitive diagnostic tools. Your insurance company will happily pay for them if it means earlier detection and treatment.
| Recommended Link | |||
|
|||
| — |
Inflection Point
So what will the effects of this technology be?
With this new technology, patient treatment will shift from a reactive, symptom-driven model to a proactive, predictive one.
Patients will no longer experience symptoms, go to the hospital feeling sick, and have a doctor treat them based on those symptoms.
Instead, they will have extensive medical histories—and outlooks—determined by predictive diagnoses.
The onset of diseases will be determined at the earliest stages, when symptoms are not at all felt by the patients. And therapies will be applied quickly—before the conditions worsen. This is when diseases are easiest to treat.
That means we will live longer, with less disease and pain. We’ll also spend much less time in hospitals than we do today. And thanks to this technology, it’s very likely that we’ll live well into our hundreds… and even have a high quality of life as we do so.
Life is going to get much better. And this shift is happening right now.
This is exactly the kind of inflection point that leads to exponential gains, and precisely what I look for in my research.
Predictive medicine has long been the ultimate goal for doctors and hospitals: being able to “see” something wrong before symptoms are present, and then take action to address conditions before they ever become issues.
Now, it’s quickly becoming a reality.
Regards,
Jeff Brown
Editor, The Near Future Report
P.S. Before you go, I want to put another tech investing trend on your radar. It’s something that will create $12 trillion in wealth and make early investors a small fortune. It will be the “backbone” of futuristic technology, like self-driving cars and augmented reality. And I’ve found the perfect way to play it…
A small company is hard at work, developing a component that will help this tech go mainstream. Believe it or not, you can get a piece of this superstar company for less than $6 a share today. See it for yourself right here…
IN CASE YOU MISSED IT…
On Wednesday, December 12, at 8 p.m. ET, Teeka Tiwari will make an EXTRAORDINARY announcement.
During this free special event, you’ll also…
-
Discover the inside scoop on an event that will transform the crypto market in 2019, and see a leaked Wall Street document that reveals what this event is
-
Get a sneak peek at our mock-up of what could become a new crypto feature of every major trading platform
-
Hear Teeka reveal—live—his bold new venture that could hand you the chance at an extra $81,624 per year
The only way to get an invitation is to sign up now. Click here to register your email and sign up for this free event…
